Several short, noncoding RNA molecules are associated with multiple sclerosis symptoms, perhaps in enough of a causal way to become therapeutic targets as well as biomarkers of disease, a researcher said here.
These so-called micro RNA species, or miRNAs, may be critical in shifting immune responsiveness away from the benign Th2 profile, instead promoting pro-inflammatory Th1/Th17 responses, said Mireia Guerau de Arellano, PharmD, PhD, of Ohio State University in Columbus.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1863